BIOCEPT INC (BIOC)
US09072V6002 - Common Stock
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -34.84M | -32.09M | -2.82M | -17.81M | -25.14M | |||
| Depreciation Amortization | 1.83M | 1.66M | 1.53M | 1.09M | 930.00K | |||
| Change In Working Capital | 15.93M | 13.29M | -552.00K | -6.27M | -1.40M | |||
| Interest Paid | 195.00K | 316.00K | 290.00K | 240.00K | 250.00K | |||
| Taxes Paid | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | -515.00K | 3.86M | 5.54M | 3.20M | 2.56M | |||
| OPERATING CASH FLOW | -17.60M | -13.29M | 3.69M | -19.79M | -23.05M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -680.00K | -807.00K | -1.57M | -870.00K | -740.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -605.00K | -807.00K | -1.57M | -870.00K | -740.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.19M | -2.11M | -1.77M | -1.54M | -930.00K | |||
| Stock Issued/Repurchased | 4.10M | 240.00K | 14.15M | 27.26M | 30.60M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 1.91M | -1.87M | 12.38M | 25.72M | 29.66M | |||
| CHANGE IN CASH | -16.30M | -15.97M | 14.50M | 5.06M | 5.87M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -17.60M | -13.29M | 3.69M | -19.79M | -23.05M | |||
| Capital Expenditure | -680.00K | -807.00K | -1.57M | -870.00K | -740.00K | |||
| FREE CASH FLOW | -18.28M | -14.10M | 2.12M | -20.66M | -23.79M | |||
All data in USD